{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:27:56Z","timestamp":1793392076791,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality and elevated costs to healthcare systems. Over the last decades the understanding of pathophysiology mechanisms, diagnostic techniques and optimal treatment intervention in MPE have been greatly advanced by recent high-quality research, leading to an ever less invasive diagnostic approach and more personalized management. Despite a number of management options, including talc pleurodesis, indwelling pleural catheters and combinations of the two, treatment for MPE remains symptom directed and centered around drainage strategy. In the next future, because of a better understanding of underlying tumor biology together with more sensitive molecular diagnostic techniques, it is likely that combined diagnostic and therapeutic procedures allowing near total outpatient management of MPE will become popular. This article provides a review of the current advances, new discoveries and future directions in the pathophysiology, diagnosis and management of MPE.<\/jats:p>","DOI":"10.1186\/s12931-024-02684-7","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T06:01:48Z","timestamp":1705644108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Malignant pleural effusion: current understanding and therapeutic approach"],"prefix":"10.1186","volume":"25","author":[{"given":"Francesca","family":"Gonnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eihab O","family":"Bedawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"2684_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mcna.2018.12.007","volume":"103","author":"M Aboudara","year":"2019","unstructured":"Aboudara M, Maldonado F. Update in the management of Pleural effusions. Med Clin North Am. 2019;103:475\u201385.","journal-title":"Med Clin North Am"},{"key":"2684_CR2","first-page":"665","volume-title":"Principles and Practice of Interventional Pulmonology","author":"A Villanueva","year":"2012","unstructured":"Villanueva A. Management of malignant pleural effusions. In: Ernst A, Herth FJ, editors. Principles and Practice of Interventional Pulmonology. New York: Springer; 2012. pp. 665\u201374."},{"key":"2684_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479\u201395.","journal-title":"Eur Respir J"},{"key":"2684_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thorax-2022-219784","volume":"78","author":"ME Roberts","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al. British thoracic Society Guideline for pleural disease. Thorax. 2023;78:1\u201342.","journal-title":"Thorax"},{"key":"2684_CR5","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.chest.2021.05.026","volume":"160","author":"SR Mummadi","year":"2021","unstructured":"Mummadi SR, Stoller JK, Lopez R, et al. Epidemiology of adult Pleural Disease in the United States. Chest. 2021;160:1534\u201351.","journal-title":"Chest"},{"key":"2684_CR6","doi-asserted-by":"publisher","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","volume":"52","author":"AC Bibby","year":"2018","unstructured":"Bibby AC, Dorn P, Psallidas I, et al. ERS\/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52:1800349.","journal-title":"Eur Respir J"},{"key":"2684_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/resp.12496","volume":"20","author":"JM Porcel","year":"2015","unstructured":"Porcel JM, Gasol A, Bielsa S, et al. Clinical features and survival of lung cancer patients with pleural effusions. Respirology. 2015;20:654\u20139.","journal-title":"Respirology"},{"key":"2684_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","volume":"69","author":"AO Clive","year":"2014","unstructured":"Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69:1098\u2013104.","journal-title":"Thorax"},{"key":"2684_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","volume":"19","author":"I Psallidas","year":"2018","unstructured":"Psallidas I, Kanellakis NI, Gerry S, et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol. 2018;19:930\u20139.","journal-title":"Lancet Oncol"},{"key":"2684_CR10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/resp.13837","volume":"25","author":"JC Quek","year":"2020","unstructured":"Quek JC, Tan QL, Allen JC, et al. Malignant pleural effusion survival prognostication in an Asian population. Respirology. 2020;25:1283\u201391.","journal-title":"Respirology"},{"key":"2684_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/resp.12874","volume":"22","author":"HM Cheah","year":"2017","unstructured":"Cheah HM, Lansley SM, Varano Della Vergiliana JF, et al. Malignant pleural fluid from mesothelioma has potent biological activities. Respirology. 2017;22:192\u20139.","journal-title":"Respirology"},{"key":"2684_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2684_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1183\/16000617.0019-2016","volume":"25","author":"I Psallidas","year":"2016","unstructured":"Psallidas I, Kalomenidis I, Porcel JM, et al. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016;25:189\u201398.","journal-title":"Eur Respir Rev"},{"key":"2684_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","volume":"186","author":"GT Stathopoulos","year":"2012","unstructured":"Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186:487\u201392.","journal-title":"Am J Respir Crit Care Med"},{"key":"2684_CR15","doi-asserted-by":"publisher","first-page":"658395","DOI":"10.3389\/fonc.2021.658395","volume":"11","author":"R Asciak","year":"2021","unstructured":"Asciak R, Kanellakis NI, Yao X, et al. Pleural Fluid has pro-growth Biological properties which enable Cancer Cell Proliferation. Front Oncol. 2021;11:658395.","journal-title":"Front Oncol"},{"key":"2684_CR16","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1183\/09031936.97.10081907","volume":"10","author":"SA Sahn","year":"1997","unstructured":"Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997;10:1907\u201313.","journal-title":"Eur Respir J"},{"key":"2684_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.athoracsur.2003.11.065","volume":"80","author":"AV Maker","year":"2005","unstructured":"Maker AV, Nguyen DM. Images in cardiothoracic surgery. Active malignant pleural effusion captured through the thoracoscope. Ann Thorac Surg. 2005;80:1941.","journal-title":"Ann Thorac Surg"},{"key":"2684_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/JTO.0b013e318208c7c1","volume":"6","author":"L Sakr","year":"2011","unstructured":"Sakr L, Maldonado F, Greillier L, et al. Thoracoscopic assessment of pleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications. J Thorac Oncol. 2011;6:592\u20137.","journal-title":"J Thorac Oncol"},{"key":"2684_CR19","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1183\/09031936.97.10081701","volume":"10","author":"RW Light","year":"1997","unstructured":"Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J. 1997;10:1701\u20132.","journal-title":"Eur Respir J"},{"key":"2684_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1378\/chest.110.2.433","volume":"110","author":"YM Chen","year":"1996","unstructured":"Chen YM, Yang WK, Whang-Peng J, et al. Elevation of interleukin-10 levels in malignant pleural effusion. Chest. 1996;110:433\u201336.","journal-title":"Chest"},{"key":"2684_CR21","first-page":"8019","volume":"17","author":"Y Chen","year":"2018","unstructured":"Chen Y, Mathy NW, Lu H. The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with nonsmall cell lung cancer (review). Mol Med Rep. 2018;17:8019\u201330.","journal-title":"Mol Med Rep"},{"key":"2684_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1165\/rcmb.2005-0130OC","volume":"34","author":"GT Stathopoulos","year":"2006","unstructured":"Stathopoulos GT, Zhu Z, Everhart MB, et al. Nuclear factor-kappab affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol. 2006;34:142\u201350.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2684_CR23","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1038\/sj.onc.1209464","volume":"25","author":"HH Yeh","year":"2006","unstructured":"Yeh HH, Lai WW, Chen HH, et al. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene. 2006;25:4300\u20139.","journal-title":"Oncogene"},{"key":"2684_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/onc.2012.57","volume":"32","author":"I Psallidas","year":"2013","unstructured":"Psallidas I, Stathopoulos GT, Maniatis NA, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene. 2013;32:528\u201335.","journal-title":"Oncogene"},{"key":"2684_CR25","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1158\/0008-5472.CAN-07-1064","volume":"67","author":"GT Stathopoulos","year":"2007","unstructured":"Stathopoulos GT, Kollintza A, Moschos C, et al. Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res. 2007;67:9825\u201334.","journal-title":"Cancer Res"},{"key":"2684_CR26","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1172\/JCI79840","volume":"125","author":"AD Giannou","year":"2015","unstructured":"Giannou AD, Marazioti A, Spella M, et al. Mast cells mediate malignant pleural effusion formation. J Clin Invest. 2015;125:2317\u201334.","journal-title":"J Clin Invest"},{"key":"2684_CR27","doi-asserted-by":"publisher","first-page":"15205","DOI":"10.1038\/ncomms15205","volume":"8","author":"T Agalioti","year":"2017","unstructured":"Agalioti T, Giannou AD, Krontira AC, et al. Mutant KRAS promotes malignant pleural effusion formation. Nat Commun. 2017;8:15205.","journal-title":"Nat Commun"},{"key":"2684_CR28","doi-asserted-by":"publisher","first-page":"e000701","DOI":"10.1136\/bmjresp-2020-000701","volume":"7","author":"RM Mercer","year":"2020","unstructured":"Mercer RM, Varatharajah R, Shepherd G, et al. Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion. BMJ Open Respir Res. 2020;7:e000701.","journal-title":"BMJ Open Respir Res"},{"key":"2684_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/thx.2008.100545","volume":"64","author":"NR Qureshi","year":"2009","unstructured":"Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax. 2009;64:139\u201343.","journal-title":"Thorax"},{"key":"2684_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1378\/chest.07-1656","volume":"133","author":"V Bandi","year":"2008","unstructured":"Bandi V, Lunn W, Ernst A, et al. Ultrasound vs. CT in detecting chest wall invasion by tumor: a prospective study. Chest. 2008;133:881\u20136.","journal-title":"Chest"},{"key":"2684_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/thorax-2022-219371","volume":"78","author":"R Asciak","year":"2023","unstructured":"Asciak R, Bedawi EO, Bhatnagar R, et al. British thoracic Society Clinical Statement on pleural procedures. Thorax. 2023;78:43\u201368.","journal-title":"Thorax"},{"key":"2684_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1378\/chest.123.2.436","volume":"123","author":"AH Diacon","year":"2003","unstructured":"Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest. 2003;123:436\u201341.","journal-title":"Chest"},{"key":"2684_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1378\/chest.123.2.418","volume":"123","author":"PW Jones","year":"2003","unstructured":"Jones PW, Moyers JP, Rogers JT, et al. Ultrasound-guided thoracentesis: is it a safer method? Chest. 2003;123:418\u201323.","journal-title":"Chest"},{"key":"2684_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/resp.12088","volume":"18","author":"M Salamonsen","year":"2013","unstructured":"Salamonsen M, Dobeli K, McGrath D, et al. Physician-performed ultrasound can accurately screen for a vulnerable intercostal artery prior to chest drainage procedures. Respirology. 2013;18:942\u20137.","journal-title":"Respirology"},{"key":"2684_CR35","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1378\/chest.14-0637","volume":"147","author":"G Marchetti","year":"2015","unstructured":"Marchetti G, Valsecchi A, Indellicati D, et al. Ultrasound-guided medical thoracoscopy in the absence of pleural effusion. Chest. 2015;147:1008\u201312.","journal-title":"Chest"},{"key":"2684_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.arbr.2019.05.018","volume":"55","author":"M Hassan","year":"2019","unstructured":"Hassan M, Asciak R, Mercer RM, et al. Echogenic swirling seen on Ultrasound and Outcome of Pleurodesis in Malignant Pleural Effusion. Arch Bronconeumol (Engl Ed). 2019;55:659\u201361.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2684_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rmed.2017.02.013","volume":"124","author":"RJ Hallifax","year":"2017","unstructured":"Hallifax RJ, Talwar A, Wrightson JM, et al. State-of-the-art: radiological investigation of pleural disease. Respir Med. 2017;124:88\u201399.","journal-title":"Respir Med"},{"key":"2684_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","volume":"154","author":"AN Leung","year":"1990","unstructured":"Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990;154:487\u201392.","journal-title":"AJR Am J Roentgenol"},{"key":"2684_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1378\/chest.14-0013","volume":"147","author":"JM Porcel","year":"2015","unstructured":"Porcel JM, Pardina M, Bielsa S, et al. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. Chest. 2015;147:513\u20139.","journal-title":"Chest"},{"key":"2684_CR40","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","volume":"73","author":"I Woolhouse","year":"2018","unstructured":"Woolhouse I, Bishop L, Darlison L, et al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax. 2018;73:i1\u201330.","journal-title":"Thorax"},{"key":"2684_CR41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/resp.12675","volume":"21","author":"JP Corcoran","year":"2016","unstructured":"Corcoran JP, Acton L, Ahmed A, et al. Diagnostic value of radiological imaging pre- and post-drainage of pleural effusions. Respirology. 2016;21:392\u20135.","journal-title":"Respirology"},{"key":"2684_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/RLU.0b013e3181bece11","volume":"34","author":"NC Nguyen","year":"2009","unstructured":"Nguyen NC, Tran I, Hueser CN, et al. F-18 FDG PET\/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study. Clin Nucl Med. 2009;34:886\u201390.","journal-title":"Clin Nucl Med"},{"key":"2684_CR43","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1378\/chest.125.6.2356","volume":"125","author":"BH Kwek","year":"2004","unstructured":"Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest. 2004;125:2356\u201360.","journal-title":"Chest"},{"key":"2684_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1378\/chest.14-0820","volume":"147","author":"JM Porcel","year":"2015","unstructured":"Porcel JM, Hernandez P, Martinez-Alonso M, et al. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. Chest. 2015;147:502\u201312.","journal-title":"Chest"},{"key":"2684_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lungcan.2021.10.018","volume":"162","author":"K Fjaellegaard","year":"2021","unstructured":"Fjaellegaard K, Koefod Petersen J, Reuter S, et al. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis. Lung Cancer. 2021;162:106\u201318.","journal-title":"Lung Cancer"},{"key":"2684_CR46","doi-asserted-by":"publisher","unstructured":"De Fonseka D, Arnold DT, Smartt HJM, et al. PET-CT guided versus CT-guided biopsy in suspected malignant pleural thickening; a randomised trial. Eur Respir J. 2023. In press. https:\/\/doi.org\/10.1183\/13993003.01295-2023.","DOI":"10.1183\/13993003.01295-2023"},{"key":"2684_CR47","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1513\/AnnalsATS.201902-189CME","volume":"16","author":"V Kaul","year":"2019","unstructured":"Kaul V, McCracken DJ, Rahman NM, et al. Contemporary Approach to the diagnosis of malignant pleural effusion. Ann Am Thorac Soc. 2019;16:1099\u2013106.","journal-title":"Ann Am Thorac Soc"},{"key":"2684_CR48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.arbres.2013.11.007","volume":"50","author":"JM Porcel","year":"2014","unstructured":"Porcel JM, Esquerda A, Vives M, et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50:161\u20135.","journal-title":"Arch Bronconeumol"},{"key":"2684_CR49","doi-asserted-by":"publisher","first-page":"1801254","DOI":"10.1183\/13993003.01254-2018","volume":"52","author":"DT Arnold","year":"2018","unstructured":"Arnold DT, De Fonseka D, Perry S, et al. Investigating unilateral pleural effusions: the role of cytology. Eur Respir J. 2018;52:1801254.","journal-title":"Eur Respir J"},{"key":"2684_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1378\/chest.08-2002","volume":"135","author":"W Abouzgheib","year":"2009","unstructured":"Abouzgheib W, Bartter T, Dagher H, et al. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest. 2009;135:999\u20131001.","journal-title":"Chest"},{"key":"2684_CR51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cncy.21452","volume":"122","author":"LM Rooper","year":"2014","unstructured":"Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014;122:657\u201365.","journal-title":"Cancer Cytopathol"},{"key":"2684_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MCP.0000000000000593","volume":"25","author":"JM Porcel","year":"2019","unstructured":"Porcel JM. Diagnosis and characterization of malignant effusions through pleural fluid cytological examination. Curr Opin Pulm Med. 2019;25:362\u20138.","journal-title":"Curr Opin Pulm Med"},{"key":"2684_CR53","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/cancers13112798","volume":"13","author":"MA Sorolla","year":"2021","unstructured":"Sorolla MA, Sorolla A, Parisi E, et al. Diving into the Pleural Fluid: Liquid Biopsy for metastatic malignant pleural effusions. Cancers (Basel). 2021;13:2798.","journal-title":"Cancers (Basel)"},{"key":"2684_CR54","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1513\/AnnalsATS.202107-810RL","volume":"19","author":"JM Porcel","year":"2022","unstructured":"Porcel JM, Sorolla A, Parisi E, et al. Cell-free DNA concentration and pattern fragmentation in Pleural Fluid and plasma to detect malignant effusions. Ann Am Thorac Soc. 2022;19:854\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"2684_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MCP.0b013e3282fe9a04","volume":"14","author":"NM Rahman","year":"2008","unstructured":"Rahman NM, Gleeson FV. Image-guided pleural biopsy. Curr Opin Pulm Med. 2008;14:331\u20136.","journal-title":"Curr Opin Pulm Med"},{"key":"2684_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000511626","volume":"100","author":"F Mei","year":"2021","unstructured":"Mei F, Bonifazi M, Rota M, et al. Diagnostic yield and safety of image-guided pleural biopsy: a systematic review and Meta-analysis. Respiration. 2021;100:77\u201387.","journal-title":"Respiration"},{"key":"2684_CR57","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0846537120939073","volume":"72","author":"M Mychajlowycz","year":"2021","unstructured":"Mychajlowycz M, Alabousi A, Mironov O. Ultrasound- versus CT-Guided Subpleural Lung and Pleural Biopsy: an analysis of wait Times, Procedure Time, Safety, and diagnostic adequacy. Can Assoc Radiol J. 2021;72:883\u20139.","journal-title":"Can Assoc Radiol J"},{"key":"2684_CR58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1148\/radiol.12112077","volume":"266","author":"LM Sconfienza","year":"2013","unstructured":"Sconfienza LM, Mauri G, Grossi F, et al. Pleural and peripheral lung lesions: comparison of US- and CT-guided biopsy. Radiology. 2013;266:930\u20135.","journal-title":"Radiology"},{"issue":"Suppl 2","key":"2684_CR59","doi-asserted-by":"publisher","first-page":"ii54","DOI":"10.1136\/thx.2010.137018","volume":"65","author":"NM Rahman","year":"2010","unstructured":"Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii54\u201360.","journal-title":"Thorax"},{"key":"2684_CR60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1378\/chest.107.3.845","volume":"107","author":"RJ Harris","year":"1995","unstructured":"Harris RJ, Kavuru MS, Mehta AC, et al. The impact of thoracoscopy on the management of pleural disease. Chest. 1995;107:845\u201352.","journal-title":"Chest"},{"key":"2684_CR61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","volume":"72","author":"C Boutin","year":"1993","unstructured":"Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis. Cancer. 1993;72:389\u201393.","journal-title":"Cancer"},{"key":"2684_CR62","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4187\/respcare.02738","volume":"59","author":"S Dhooria","year":"2014","unstructured":"Dhooria S, Singh N, Aggarwal AN, et al. A randomized trial comparing the diagnostic yield of rigid and semirigid thoracoscopy in undiagnosed pleural effusions. Respir Care. 2014;59:756\u201364.","journal-title":"Respir Care"},{"key":"2684_CR63","doi-asserted-by":"publisher","first-page":"6746470","DOI":"10.1155\/2018\/6746470","volume":"2018","author":"CH Chen","year":"2018","unstructured":"Chen CH, Cheng WC, Wu BR, et al. Feasibility and safety of Pleuroscopic Cryobiopsy of the Pleura: a prospective study. Can Respir J. 2018;2018:6746470.","journal-title":"Can Respir J"},{"key":"2684_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000497212","volume":"98","author":"S Dhooria","year":"2019","unstructured":"Dhooria S, Bal A, Sehgal IS, et al. Pleural Cryobiopsy versus flexible forceps biopsy in subjects with undiagnosed Exudative Pleural effusions Undergoing Semirigid Thoracoscopy: a crossover randomized trial (COFFEE trial). Respiration. 2019;98:133\u201341.","journal-title":"Respiration"},{"key":"2684_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chest.2019.09.023","volume":"157","author":"M Shafiq","year":"2020","unstructured":"Shafiq M, Sethi J, Ali MS, et al. Pleural Cryobiopsy: a systematic review and Meta-analysis. Chest. 2020;157:223\u201330.","journal-title":"Chest"},{"key":"2684_CR66","doi-asserted-by":"publisher","first-page":"847146","DOI":"10.3389\/fmed.2022.847146","volume":"9","author":"M Giri","year":"2022","unstructured":"Giri M, Dai H, Guo S, et al. Efficacy and Safety of Pleural Cryobiopsy vs. forceps biopsy for evaluation of undiagnosed Pleural Effusion: a systematic review and Meta-analysis. Front Med (Lausanne). 2022;9:847146.","journal-title":"Front Med (Lausanne)"},{"key":"2684_CR67","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1440-1843.2011.01973.x","volume":"16","author":"CF Koegelenberg","year":"2011","unstructured":"Koegelenberg CF, Diacon AH. Pleural controversy: close needle pleural biopsy or thoracoscopy-which first? Respirology. 2011;16:738\u201346.","journal-title":"Respirology"},{"issue":"Suppl 2","key":"2684_CR68","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/thx.2010.136986","volume":"65","author":"A MacDuff","year":"2010","unstructured":"MacDuff A, Arnold A, Harvey J, et al. Management of spontaneous pneumothorax: British thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18\u201331.","journal-title":"Thorax"},{"key":"2684_CR69","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1001\/jama.2015.16840","volume":"314","author":"NM Rahman","year":"2015","unstructured":"Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on Pain Control and Pleurodesis Efficacy among patients with malignant pleural effusion: the TIME1 Randomized Clinical Trial. JAMA. 2015;314:2641\u201353.","journal-title":"JAMA"},{"key":"2684_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jama.2019.19997","volume":"323","author":"R Bhatnagar","year":"2020","unstructured":"Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, et al. Effect of Thoracoscopic Talc Poudrage vs talc slurry via Chest Tube on Pleurodesis failure rate among patients with malignant pleural effusions: a Randomized Clinical Trial. JAMA. 2020;323:60\u20139.","journal-title":"JAMA"},{"key":"2684_CR71","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1001\/jama.2012.5535","volume":"307","author":"HE Davies","year":"2012","unstructured":"Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307:2383\u20139.","journal-title":"JAMA"},{"key":"2684_CR72","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2017.17426","volume":"318","author":"R Thomas","year":"2017","unstructured":"Thomas R, Fysh ETH, Smith NA, et al. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017;318:1903\u201312.","journal-title":"JAMA"},{"key":"2684_CR73","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","volume":"195","author":"MM Wahidi","year":"2017","unstructured":"Wahidi MM, Reddy C, Yarmus L, et al. Randomized Trial of Pleural Fluid Drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195:1050\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"2684_CR74","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","volume":"6","author":"S Muruganandan","year":"2018","unstructured":"Muruganandan S, Azzopardi M, Fitzgerald DB, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6:671\u201380.","journal-title":"Lancet Respir Med"},{"key":"2684_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13063-015-0563-y","volume":"16","author":"R Bhatnagar","year":"2015","unstructured":"Bhatnagar R, Kahan BC, Morley AJ, et al. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial. Trials. 2015;16:48.","journal-title":"Trials"},{"key":"2684_CR76","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13063-022-06405-7","volume":"23","author":"DB Fitzgerald","year":"2022","unstructured":"Fitzgerald DB, Sidhu C, Budgeon C, et al. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (+\/-talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. Trials. 2022;23:530.","journal-title":"Trials"},{"key":"2684_CR77","doi-asserted-by":"publisher","first-page":"210025","DOI":"10.1183\/16000617.0025-2021","volume":"30","author":"A Dipper","year":"2021","unstructured":"Dipper A, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: an updated network meta-analysis. Eur Respir Rev. 2021;30:210025.","journal-title":"Eur Respir Rev"},{"key":"2684_CR78","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1378\/chest.127.3.909","volume":"127","author":"CM Dresler","year":"2005","unstructured":"Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909\u201315.","journal-title":"Chest"},{"key":"2684_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2217\/fon.15.274","volume":"11","author":"RC Rintoul","year":"2015","unstructured":"Rintoul RC. The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy? Future Oncol. 2015;11:15\u20137.","journal-title":"Future Oncol"},{"key":"2684_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S2213-2600(21)00353-2","volume":"10","author":"I Psallidas","year":"2022","unstructured":"Psallidas I, Hassan M, Yousuf A, et al. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial. Lancet Respir Med. 2022;10:139\u201348.","journal-title":"Lancet Respir Med"},{"key":"2684_CR81","doi-asserted-by":"publisher","first-page":"1053574","DOI":"10.3389\/fonc.2022.1053574","volume":"12","author":"DN Addala","year":"2022","unstructured":"Addala DN, Kanellakis NI, Bedawi EO, et al. Malignant pleural effusion: updates in diagnosis, management and current challenges. Front Oncol. 2022;12:1053574.","journal-title":"Front Oncol"},{"key":"2684_CR82","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/thorax-2022-219449","volume":"78","author":"MA Mitchell","year":"2023","unstructured":"Mitchell MA, Deschner E, Dhaliwal I, et al. Patient perspectives on the use of indwelling pleural catheters in malignant pleural effusions. Thorax. 2023;78:1111\u20137.","journal-title":"Thorax"},{"key":"2684_CR83","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/resp.14451","volume":"28","author":"CJ Peddle-McIntyre","year":"2023","unstructured":"Peddle-McIntyre CJ, Muruganandan S, McVeigh J, et al. Device assessed activity behaviours in patients with indwelling pleural catheter: a sub-study of the Australasian Malignant PLeural Effusion (AMPLE)-2 randomized trial. Respirology. 2023;28:561\u201370.","journal-title":"Respirology"},{"key":"2684_CR84","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1513\/AnnalsATS.202111-1301OC","volume":"19","author":"JB Shrager","year":"2022","unstructured":"Shrager JB, Bhatnagar R, Kearney CT, et al. Silver nitrate-coated versus standard indwelling Pleural Catheter for malignant effusions: the SWIFT Randomized Trial. Ann Am Thorac Soc. 2022;19:1722\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"2684_CR85","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1164\/rccm.201704-0809OC","volume":"197","author":"EK Mishra","year":"2018","unstructured":"Mishra EK, Clive AO, Wills GH, et al. Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion. Am J Respir Crit Care Med. 2018;197:502\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"2684_CR86","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.chest.2021.04.042","volume":"160","author":"DN Addala","year":"2021","unstructured":"Addala DN, Rahman NM, Maldonado F. Personalized prognostication in malignant pleural effusion: the next step? Chest. 2021;160:805\u20136.","journal-title":"Chest"},{"key":"2684_CR87","first-page":"e41689","volume":"15","author":"AM Peel","year":"2023","unstructured":"Peel AM, Mishra EK. The Psychosocial Impact of Indwelling Pleural catheters: a scoping review. Cureus. 2023;15:e41689.","journal-title":"Cureus"},{"key":"2684_CR88","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.chest.2021.03.059","volume":"160","author":"S Molina","year":"2021","unstructured":"Molina S, Martinez-Zayas G, Sainz PV, et al. Breast and lung effusion survival score models: improving survival prediction in patients with malignant pleural effusion and metastasis. Chest. 2021;160:1075\u201394.","journal-title":"Chest"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02684-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T07:05:09Z","timestamp":1705647909000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2684"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02684-7","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FM serves as an Associate Editor on the Editorial Board of the Journal.The remaining authors have no conflict of interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}